Open AccessThe effect of certolizumab drug concentration and anti-drug antibodies on TNF neutralisation
Author(s) -
Lea C. Berkhout,
Erik H Vogelzang,
Margreet M Hart,
Floris C. Loeff,
Lisanne Dijk,
Ninotska I. L. Derksen,
Roeland Wieringa,
W.A. van Leeuwen,
C. Krieckaert,
Annick de Vries,
M.T. Nurmohamed,
Gertjan Wolbink,
Theo Rispens
Publication year - 2020
Publication title -
clinical and experimental rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.184
H-Index - 95
eISSN - 1593-098X
pISSN - 0392-856X
DOI - 10.55563/clinexprheumatol/nlr4r8
Subject(s) - adalimumab , medicine , rheumatoid arthritis , certolizumab pegol , tumor necrosis factor alpha , infliximab , pharmacology , gastroenterology , immunology